Latest News and Press Releases

Dallas, TX, April 30, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading health tech innovator in wearable neurostimulation technology, has closed its $15M Series A round—led by WAVE Ventures and...

Dallas, TX, March 24, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal phase II clinical trial, offering hope to...

OAKLAND, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Patients who struggle with opioid addiction and who are treated by California emergency department physicians are remarkably successful at...

NYC Building & Construction Industry Safety Fund program will equip local workers, contractors and staff with NARCAN® Nasal Spray and provide trainings on how to administer the life-saving...

Dallas, TX, March 05, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow...

BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Bicycle Health, the nation’s largest provider of virtual opioid use disorder (OUD) treatment, raised $16.5M in funding led by existing investor Questa...

Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to distribute multiple life-saving opioid overdose emergency...

TEMECULA, Calif, Dec. 10, 2024 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, announces the launch...

Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measuresOne-year mark of Ready to Rescue public awareness campaign to expand awareness,...

Dallas, TX, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Dallas, TX [August 2024] – Spark Biomedical, Inc., a leader in non-invasive neurostimulation technology, has been issued two unique Healthcare Common...